EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Agentix's enterprise value is $1.52 Mil.
Agentix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Agentix's EV-to-Revenue for today is .
The historical rank and industry rank for Agentix's EV-to-Revenue or its related term are showing as below:
During the past 9 years, the highest EV-to-Revenue of Agentix was 9218.50. The lowest was 44.92. And the median was 339.00.
AGTX's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.86 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-06-08), Agentix's stock price is $0.03545.
Agentix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, Agentix's PS Ratio for today is .
Agentix EV-to-Revenue Historical Data
The historical data trend for Agentix's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Agentix's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agentix's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Agentix's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Agentix's EV-to-Revenue falls into.
Agentix's current Enterprise Value is $1.52 Mil.
Agentix's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agentix's share price for today is $0.03545.
Agentix's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agentix EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Agentix's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Agentix Corp is a biotechnology company. It is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. Its principal business objective is to develop both science-driven synthetic and natural cannabinoid therapeutics that address unmet medical needs and continue to drive innovations in the endocannabinoid space.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AGTX has been successfully added to your 